Construction of a heterologous vaccine against Bordetella avium and Campylobacter jejuni utilizing the B. avium transporter, Baa1 by Korba, Rachel
James Madison University 
JMU Scholarly Commons 
Senior Honors Projects, 2010-2019 Honors College 
Spring 2017 
Construction of a heterologous vaccine against Bordetella avium 
and Campylobacter jejuni utilizing the B. avium transporter, Baa1 
Rachel Korba 
James Madison University 
Follow this and additional works at: https://commons.lib.jmu.edu/honors201019 
 Part of the Biotechnology Commons 
Recommended Citation 
Korba, Rachel, "Construction of a heterologous vaccine against Bordetella avium and Campylobacter 
jejuni utilizing the B. avium transporter, Baa1" (2017). Senior Honors Projects, 2010-2019. 259. 
https://commons.lib.jmu.edu/honors201019/259 
This Thesis is brought to you for free and open access by the Honors College at JMU Scholarly Commons. It has 
been accepted for inclusion in Senior Honors Projects, 2010-2019 by an authorized administrator of JMU Scholarly 
Commons. For more information, please contact dc_admin@jmu.edu. 
Construction of a Heterologous Vaccine against Bordetella avium and Campylobacter jejuni 
utilizing the B. avium Transporter, Baa1 
_______________________ 
 
An Honors College Project Presented to 
 
the Faculty of the Undergraduate 
 
College of Integrated Science and Technology and College of Science and Mathematics 
 










Accepted by the faculty of the Department of Integrated Science and Technology, James Madison University, in 





       
Project Advisor:  Louise Temple, Ph.D., 




       
Reader:  Stephanie Stockwell, Ph.D., 
Associate Professor, Department of Integrated 
Science and Technology 
 
 
       
Reader:  Christopher Berndsen, Ph.D., 
Assistant Professor, Department of Chemistry 
 
HONORS COLLEGE APPROVAL: 
 
 
       
Bradley R. Newcomer, Ph.D., 




This work is accepted for presentation, in part or in full, at the Integrated Science and Technology Symposium on 




Table of Contents 
List of Figures                                                                                                                                  3 
Acknowledgements                                                                                                                          4 
Abstract                                                                                                                                            5 
Introduction                                                                                                                                      6 
Materials and Methods                                                                                                                   10 
Results                                                                                                                                            18 
Discussion                                                                                                                                      27 
Supplemental Data                                                                                                                         31 





List of Figures 
Tables 
1  Primers for the Synthesized Plasmid used in Verification of Homologous Recombination                                                                               
                   17 
 
Figures 
1  Plasmid Construct of Chimeric baa1 containing flaA/ cjaA in the Passenger Domain     12 
2  Map of the Synthesized Plasmid Containing the GC-Optimized cjaA Region                 16  
3  Confirmation of the Ligation and Transformation of cjaA and flaA into pB154              18 
4  Tri Parental Mating Selection Plates                                                                                  19 
5  Verification of Amplifiable Regions in the Putative Transconjugants                              20 
6  Tri Parental Mating Selection Plate with Synthesized Plasmid                                         21 
7  Verification of the First Crossover using a Temperature Gradient PCR                           22 
8  Verification of the First Crossover using a Temperature Gradient PCR Using CjaO-F and 
ProCjaTra-R Primer Combination                                                                                     23 
9  Flow Chart Diagram and Results of Mixed Colony Morphology Study                           24 
10  Verification of the Second Crossover on Ten Different Passaged B. avium 
Transconjugants                                                                                                                 25  
11  Verification of Recombinant B. avium clones containing the baa1::cjaA construct         26 
Supplemental Tables 
1  Primers for the Synthesized Plasmid Containing the Optimized ProCjaTra Gene            31 
Supplemental Figures 
1  Campylobacter Regions Absent in the B. avium Chromosome                                         32 





I would like to express my gratitude to my advisor, Dr. Louise Temple for her immense 
amount of advice and guidance. I also acknowledge the other members of my committee, Dr. 
Stephanie Stockwell and Dr. Christopher Berndsen, for their aid in the writing of my thesis. 
Furthermore, I acknowledge Kiran Nehra from the DCR University of Science and Technology 
as well as previous students from the Temple lab for their contributions on this project. Finally, I 
would like to acknowledge the Honors College and Department of Integrated Science and 
Technology for the funding and facilities to complete this research project and present it at 





A Gram negative species of bacteria, Campylobacter jejuni, is the leading cause of food 
poisoning worldwide. Humans often contract food poisoning after ingesting contaminated 
poultry. Detecting the presence of C. jejuni in poultry is difficult because it is part of the natural 
flora and does not cause symptomatic infection. In a related manner, Bordetella avium is a Gram 
negative species of bacteria that causes bordetellosis in poultry. This disease is similar to 
whooping cough caused by the related pathogen of humans, B. pertussis. Though the mortality 
rate for bordetellosis is low, it weakens the birds’ immune systems, often leading to secondary 
infections. The aim of this project was to construct a vaccine platform capable of immunizing 
poultry against both pathogens—B. avium and C. jejuni—thus reducing disease in birds and 
humans. A heterologous construct can be made utilizing the B. avium autotransporter Baa1 that 
plays a role in host cell attachment. Autotransporters are comprised of three genetic regions: 
promoters to drive expression, and encoded passenger and transporter domains. The transporter 
is a beta barrel anchored in the outer membrane. The passenger domain is translocated through 
the transporter and secreted to the outer surface of the bacterial cell. An antigenic Campylobacter 
gene was cloned into the encoded passenger domain of the Baa1 autotransporter in the context of 
a suicide plasmid. Tri-parental mating was done to promote homologous recombination of the 
construct into the B. avium chromosome. After concluding the construct was not in the 
chromosome most likely due to instability, a plasmid was synthesized and the codons of the 
Campylobacter region were optimized. Tri-parental mating was completed again. All steps were 
verified with PCR and gel electrophoresis. A B. avium transconjugant containing the chimeric 
cja::baa1 construct was isolated.  Future work will involve gene expression and challenge 





Though not frequently known as a major concern of human health, Campylobacter jejuni 
is a Gram negative bacterial species that is the leading cause of gastroenteritis worldwide (1). In 
1996, C. jejuni was detected in stool samples at a higher rate than notorious food-borne disease 
agents, Salmonella and Shigella combined (1).  It is also more prevalent than E. coli O157: H7 
(1). Although there are fourteen different species of Campylobacter, 99% of human infections 
are caused by C. jejuni. Symptoms of gastrointestinal illness caused by C. jejuni include 
diarrhea, fever, and abdominal cramps. The spread of this disease in humans is mainly through 
contaminated poultry. In the USA, Europe, and Australia, 50%-70% of all Campylobacter 
infections have been attributed to consumption of chicken (1). This food-borne pathogen is of 
great concern, especially in the poultry industry.  
Another bacterial species of concern in the poultry industry is Bordetella avium. B avium 
is a Gram negative bacterium that causes bordetellosis in turkeys. Bordetellosis is similar to 
whooping cough in humans, which is caused by another Bordetella species—B. pertussis (2). B. 
avium colonizes many bird species, including commercially grown and wild birds (3), but only 
causes disease in commercially grown turkeys (2). It is naturally avirulent in chickens, but can 
still colonize them (2). The mortality rate for the disease in turkeys is low, however, bordetellosis 
results in the weakening of many young turkeys’ immune systems thus allowing opportunistic 
pathogens to infect the birds. Collectively, this causes several million dollars in losses to the U.S. 
turkey industry each year (2). Furthermore, bordetellosis also impairs the growth of turkeys, 
adding to the financial loss that the industry suffers (2). Since B. avium is found in poultry and 




particularly pressing issue in the local economy in which the largest poultry industry in the 
nation is located.  
Though seemingly disconnected issues, C. jejuni and B. avium are related because they 
are both found in poultry. Though one pathogen infects humans and one infects poultry, a 
vaccine can be made to immunize against both utilizing the B. avium cellular machinery. A new 
or improved vaccine against C. jejuni to protect human health is needed. Utilizing the 
colonization capabilities of B. avium to ciliated cells in poultry (described in more detail below), 
a dual vaccine platform is proposed that will combat both B. avium and C. jejuni. This duel 
vaccine would primarily aim to protect against C. jejuni infections in humans and B. avium in 
poultry. Preventing economic loss to the poultry industry would be an indirect positive outcome. 
B. avium (as well as all infectious Bordetella species) has a preference for attaching to the 
ciliated cells of its host (4). B. avium attaches to turkey tracheal epithelial cells (2). The 
autotransporter, Baa1, is thought to play a role in B. avium attachment and virulence (5). In many 
Gram negative species, autotransporters make up the largest protein family (6). They are usually 
comprised of a C-terminal beta-barrel-shaped transporter domain anchored in the outer 
membrane and an N-terminal passenger domain that crosses the outer membrane through the 
beta barrel to be exposed on the cell surface. The autotransporter Baa 1 is considered a virulence 
factor with the passenger domain contributing to the virulence of the pathogen, though 
autotransporters may serve other purposes. Some examples autotransporter-mediated virulence 
mechanisms include protein/ lipid degradation, serum resistance, and host cell attachment (5). 
While N-terminal passenger domains are similar in structure between different bacterial species, 
their functions vary greatly. The C terminal beta-barrel domain is a highly conserved structure 




 Stockwell et. al. (2011) provided a functional analysis of the first putative B. avium 
autotransporter, Baa1. The baa1 sequence was predicted utilizing bioinformatics; a 48% 
similarity at the amino acid level was seen between Baa1 and the known E.coli tissue adhesion 
autotransporter, AIDA-I (7). Due to the similarity of Baa1 to AIDA-1, it was hypothesized that 
Baa1 is involved in B. avium host cell attachment. To test this hypothesis, a knockout mutant 
was created (i.e., ∆baa1). Loss of the baa1 gene resulted in a decrease of attachment to turkey 
tracheal cells (8). The mean percentage of attachment of wild type cells was 5.17% whereas the 
mean of the knockout mutant was 0.89% (8). This significant difference in attachment signified 
that Baa1 plays a role in B. avium attachment to turkey tracheal cells (8).  
The Baa1 autotransporter in B. avium is a good candidate for a heterologous vaccine 
combating B. avium and C. jejuni because the mutant still attaches to the host, but is less virulent 
than the wild type (5). If an antigenic Campylobacter region is substituted for the wild type 
passenger domain, the C. jejuni protein will be secreted to the surface of the cell via the B. avium 
transporter domain. This chimera will plausibly result in the recognition of both bacterial cells by 
the turkey host’s immune system thus effectively immunizing against C. jejuni and B. avium. 
The method and location of host cell attachment of B. avium in poultry validates the suitability of 
a potential live vaccine.  
In this work, a heterologous vaccine was built by using molecular techniques to make a 
construct containing a C. jejuni gene in the passenger domain in place of the wild type B. avium 
passenger domain.  FlaA and CjaA were two C. jejuni antigenic proteins that were used to 
replace the Baa1 passenger domain. FlaA is a flagellar protein and CjaA is an outer membrane 
protein (9). The known antigenicity of these proteins increase the likelihood that the host turkey 




included constructing the Baa1 autotransporter to contain the foreign gene of interest (i.e., CjaA 
or FlaA) in the passenger domain on a B. avium suicide plasmid, and then transferring the 
construct from the E. coli suicide plasmid into the chromosome of B. avium by means of tri-
parental mating. Allelic exchange was then confirmed. Expression, attachment, and in vivo 





Materials and Methods 
Construction of the baa1::cjaA and baa1::flaA Suicide Plasmids 
Plasmid DNA Extraction 
Qiagen QuickLyse MiniPrep kit (Valencia, CA) was used to extract plasmids containing 
cjaA and flaA  (unpublished, Temple, L.M.). Bacterial suspensions of each E. coli strain 
containing the aforementioned plasmids were made by swabbing colonies from a plate into 2 mL 
of sterile water. Using materials from the kit, cells from 1.5 mL of suspension were pelleted by 
centrifugation then resuspended in 400 µL of ice cold lysis solution. The lysate was incubated at 
room temperature for 3 minutes then transferred to a column, and centrifuged for 1 minute at 
13,000 rpm. Next, 400 µL QLW buffer was added and centrifuged again. The spin column was 
transferred to a new microcentrifuge tube and 50 µL of the provided elution buffer was added to 
the column and centrifuged for 1 minute to release the plasmid DNA. The preparation was 
analyzed by gel electrophoresis and Nanodrop.  
Restriction Enzyme Digest of the B154 Backbone and PCR of the C. jejuni Inserts  
A double digest of plasmid B154 (containing the promoter and transporter regions 
consecutively) was performed.  The digest contained the following: 110 µL mini prep B154 
plasmid DNA, 1.5 µL AgeI enzyme, and 12 µL NE Buffer I. The digest was incubated at 37°C 
overnight and confirmed by gel electrophoresis. Next, 1.5 µL of the NruI enzyme and 13 µL of 
NE Buffer 3 were added to the previous digest of AgeI. The digest was incubated at 37°C 
overnight and confirmed by gel electrophoresis.   
The cjaA and flaA inserts were amplified from their respective plasmids to isolate them 
using Polymerase Chain Reaction (PCR). The total volume of the reaction was19 µL and 




reverse primer, and a colony of the E. coli with the respective C. jejuni inserts. The samples were 
run at the following settings: 1 cycle of 95°C for 2 minutes, 95°C for 15 seconds, 30 cycles of 
47°C for 1 minutes, 68°C for 1 minute, and 1 cycle of 68°C for 5 minutes. 
DNA Ligation and Transformation 
The double-digested B154 plasmid containing the promoter and transporter regions was 
ligated with the PCR products of flaA or cjaA using the Quick Ligation™ kit (Valencia, CA) 
(Figure 1). The ligation mixture for cjaA was: 2µL concentrated plasmid, 8µL PCR product of 
double-digested cjaA, 10µL 2X Quick Ligation Buffer, and 1µL T4 DNA Ligase. The ligation 
mixture for flaA was: 5µL concentrated plasmid, 5µL PCR product of double digested flaA, 
10µL 2X Quick Ligation Buffer, and 1µL T4 DNA Ligase. The tubes were mixed thoroughly 
and centrifuged briefly before incubating at room temperature for 20-30 minutes and then stored 
in the freezer.  
T7 Express competent E. coli cells (NEB, Ipswich, MA) were thawed on ice for 10 
minutes. Next, 5µL of each ligation mix was added to separate tubes and put on ice for 30 
minutes. The tubes were heat shocked at 42°C for exactly 10 seconds and then immediately 
transferred to ice for five minutes.  Next, 950µL room temperature SOC was pipetted into each 
tube and then the tubes were placed in the 37°C shaker for 60 minutes. Meanwhile, ampicillin 
selection plates (100 µg/mL) were warmed in the 37°C incubator. After shaking, the tubes were 
mixed by flicking and inverting. Then, 250µL of the transformed cells were spread on one plate.   
The remaining cell/ligation mixture was spread on another  





Figure 1. Plasmid Construct of Chimeric baa1 containing flaA/ cjaA in the Passenger 
Domain. The flaA region was inserted into the wild type passenger domain using AgeI sites. A 
similar plasmid—containing the cjaA region—was also made. The flaA/ cjaA regions were 
inserted in the B154 backbone. 
Polymerase Chain Reaction 
Putative baa1::cjaA and baa1::flaA clones were amplified using Polymerase Chain 
Reaction (PCR) to confirm the presence of the flaA and cjaA genes. The reaction mixture had a 
total volume of 19 µL and consisted of 10µL of GoTaq Green polymerase, 8 µL dH2O (with the 
exception of the positive control which had 7 µL), 0.5 µL forward primer, 0.5 µL reverse primer, 
and a colony of the transformed E. coli with the respective plasmid transformed into it. The 
positive control contained 1µL of the respective flaA/ cjaA DNA from the plasmid that the 




95°C for 2 minutes, 95°C for 15 seconds, 30 cycles of 47°C for 1 minutes, 68°C for 1 minute, 
and 1 cycle of 68°C for 5 minutes.   
Putative transconjugants in B. avium were amplified using PCR to confirm the presence 
of the flaA and cjaA genes. The reaction mixture had a total volume of 20 µL and consisted of 10 
µL of KOD Master Mix (Sigma-Aldrich, St. Louis, MO), 7 µL dH2O (with the exception of the 
negative control which had 8 µL), 0.5µL forward primer, 0.5µL reverse primer, and 1 µL of 40 
ng/µL extracted chromosomal DNA from the putative transconjugants. The positive control 
contained 1µL of the plasmid DNA. The samples were run using the same thermocyles as 
described above. The only changes were the annealing temperatures (which were dependent 
upon the primers used; see results) and the temperature of extension (70°C). 
Gel Electrophoresis 
PCR products were observed using gel electrophoresis. One percent agarose gels were 
made using 0.5 g agarose, 50mL 1X TAE buffer, and one microliter of 10mg/mL ethidium 
bromide.   A 1 kb ladder (NEB, Ipswich, MA) was used as the standard. The gels were run at 110 
volts/400 amps for approximately 40 minutes. Gels were imaged on a Bio-Rad ChemiDoc MP 
imager.  
Movement of baa1::flaA/ baa1::cjaA Construct into the B. avium Chromosome 
Tri-Parental Mating 
 The positive baa1::flaA and baa1::cjaA E. coli clones were mated with B. avium 197N 
(10) with the help of E. coli/pRK2013 (11) to facilitate homologous recombination (12). A 
bacterial suspension of each strain was made by swabbing colonies from a plate into 3mL of LB 
broth. All suspensions were normalized to and optical density (OD) at 600nm of 1.0 (12). Next, 




suspension and 50µL of the E. coli flaA or cjaA suspensions in a microcentrifuge tube. Five 
hundred microliters of each mating mixture was plated on a thin LB plate to provide absorption 
and allow for close contact. The plated mixtures were incubated at 37°C for 6-8 hours. Then, the 
mating mixtures were transferred to the selection plates (150µg/mL kanamycin, 30µg/mL 
naladixic acid, 100µg/ mL ampicillin) using cotton swabs in a single primary streak. Negative 
controls were mock mating mixtures, containing the recombinant E. coli clones, E.coli/pRK2013 
(11), and B. avium 197N. The selection plates were incubated for 24 hours, after which the 
secondary and tertiary streaks were completed and incubated at 37°C for 48 hours.  If single 
colonies were observed, DNA was extracted from each clone by the DNeasy kit (Quiagen, 
Valencia, CA). When using the synthesized plasmid clone in the tri-parental mating, only 
kanamycin and naladixic acid (not ampicillin) were used as selective agents.  
 The resulting colonies were patched on plates containing kanamycin as the selectable 
marker. The constant antibiotic pressure insured stability of the integrated plasmid. PCR was 
used to screen the putative transconjugants for the foreign Campylobacter region after passaging 
on kanamycin plates. Once verified, the kanamycin selection was removed and the putative 
transconjugants were passaged in LB broth to encourage a second crossover event. One colony 
was inoculated into 2 mL LB Broth. A dilution series of the passaged clones was made and 100 
µL of the 10-6, 10-7, and 10-8 dilutions were plated to obtain individual colonies. Chromosomal 
DNA was extracted from each colony and the second homologous crossover was verified by 
PCR.    
DNA Extraction of B. avium 
 The Qiagen DNeasy Blood and Tissue kit (Valencia, CA) was used to extract 




centrifuged for one minute at 14,000 rpm and the supernatant was removed. The pellet was 
resuspended in 200µL PBS. Next, 20µL proteinase K was added and incubated at 37°C for 15 
minutes. Then, 200µL Buffer AL was added. After vortexing, the mixture was incubated at 56°C 
for 10 minutes immediately followed by the addition of 200µL of 100% ethanol. After 
transferring the mixture to a mini spin column, the column was centrifuged at 8,000 rpm for one 
minute. Next, 500µL Buffer AW2 was added and the column was centrifuged at 14,000 rpm for 
three minutes. The DNA was eluted with 100µL of hot distilled water and incubated at room 
temperature for 1 minute. The column was centrifuged for one minute at 8,000 rpm. The released 
and captured DNA was saved; the concentration of which was measured by Nanodrop.   
Construct Synthesis and Codon Optimization 
 The inability to isolate stable single crossover clones of B. avium carrying the 
recombinant flaA or cjaA plasmid led to the decision to have the construct synthesized by 
Invitrogen (Carlsbad, CA). The cjaA gene was used as the foreign antigen insert between the 
promoter and transporter regions of baa1 (Figure 2) because the cjaA gene was shorter and 
therefore cheaper to have synthesized. The GC content of the synthesized cjaA coding region 
was optimized that match that of B. avium; C. jejuni has a 35% GC content whereas B. avium is 
61% GC. The program used for this optimization was http://genomes.urv.es/OPTIMIZER/. A 













Figure 2. Map of the Synthesized Plasmid Containing the GC-Optimized cjaA Region. The 
synthesized plasmid was 3855 bp long, with a 1577 bp long baa1::cjaA region.  
Primer Design 
 Primers  were made to amplify a region of the newly synthesized construct using the 
computer program SnapGene (Table 1). One primer pair was selected to flank the promoter/ 
transporter regions and another was made to flank the cjaA region. They were all designed to be 
around 20 base pairs long, with annealing temperature close to 65°C (Table 1).  Similar 
annealing temperatures allows for amplification using different combinations of primers. These 














Table 1. Primers for the Synthesized Plasmid used in Verification of Homologous 
Recombination                                                                                
Primer 
Combination 

















Colony Morphology Study 
 An investigation of the colony morphology (i.e., size) of the transconjugants was done by 





 The initial goal was to produce a plasmid containing the baa1 promoter and transporter-
encoding region fused to a portion of cjaA or flaA (Figure 1). PCR was utilized to amplify the C. 
jejuni genes. The amplified PCR products were ligated with the double digested B154 (AgeI and 
NruI) plasmid backbone and transformed into E. coli. Successful ligation/transformation was 
verified by growth on ampicillin selection plates and colony PCR of the cjaA and flaA regions 
(Figure 3). Clones CjaA-10 and CjaA-13 tested positive for the recombinant plasmid (Figure 3). 
One clone, FlaA-14, was positive for the recombinant plasmid.  
 
Figure 3. Confirmation of the Ligation and Tranformation of cjaA and flaA into pB154.  Gel 
electrophoresis showing the cjaA and flaA genes were successfully ligated in between the 
promoter and transporter region of Baa1 in the E. coli vector B154. The gel of samples to test 
the cjaA-containing clones is on the left; flaA-containing samples were assessed in the gel on the 
right. The arrows indicate the positive control bands of cjaA (~800 bp) and flaA (~900 bp). The 
sample bands (lanes 10 and 13 (left) and 14 (right)) were the correct size.  




 The successfully transformed E. coli strains were propagated using LB plates containing 
ampicillin.  Glycerol stocks were made for long-term storage. Next, a tri-parental mating was 
performed with one of the transformed E. coli strains for each Campylobacter insert: CjaA-13 
and FlaA-14. Many colonies grew on the kan/amp/nal selection plates (Figure 4). Chromosomal 
DNA was extracted from colonies on the tri-parental mating selection plates. Using the same 
flaA/ cjaA primers used to verify the E.coli transformation, single crossovers events into B. 
avium 197N were assessed via PCR. Neither the cjaA nor the flaA regions were present in the 
putative transconjugants. Different combinations of primers, different annealing temperatures, 
and different DNA polymerases were used to verify the first crossover—with no success. During 
this PCR optimization process, only nonspecific products were observed. In other cases, no 
bands were observed in association with the isolated B. avium transconjugants (Figure S1). A 
purified recombinant plasmid (pB154(cjaA) or pB154(flaA))was used as the positive controls in 
all experiments and yielded visible bands at their respective locations each time.  
Figure 4. Tri Parental Mating Selection Plates. Resulting growth after the tri-parental mating 
with the ligated plasmid, B. avium 197N, and pRK2013. The negative control plate testing the 
three strains individually is on the left, the cjaA mating is in the center, and the flaA mating is on 
the right.  Note the numerous individual colonies on both the cjaA and flaA plates.  It is atypical 
to obtain so many putative transconjugants following a mating procedure. 
PCR was done on the putative transconjugants to amplify the promoter region of the baa1 
gene.  This was done to ascertain the quality of our purified chromosomal DNA.  That is, if it 




plasmids were used as positive controls. All putative transconjugants showed a band at the 









Figure 5. Verification of Amplifiable Regions in the Putative Transconjugants. Gel 
electrophoresis showing that the baa1 promoter region (251 bp) of the B. avium chromosome 
were amplifiable in clones F1, F2, C1, and C2.  
 With the results that the cjaA and flaA regions were not amplifiable (Figure S1), but other 
regions (such as the promoter region and the kanamycin resistance gene) (Figure S2) were, we 
concluded that the Campylobacter genes were unstable in a B. avium background due to 
incompatibility of GC content.  As a result, we decided to abandon the manual cloning method in 
lieu of purchasing a synthesized version of the desired plasmid. In this version of the cjaA 
construct, we optimized the cjaA encoding fragment to better match the GC content of B. avium 
(61%). Only one plasmid was synthesized and it contained the optimized cjaA gene in between 
the promoter and transporter region of baa1 (Figure 2) because the cjaA gene was shorter than 
flA and therefore cheaper to have synthesized. The purchased plasmid contained a kanamycin 




 The newly synthesized plasmid was transformed into E. coli and recombinant clones 
were confirmed by PCR.  Another tri-parental mating was done utilizing E. coli containing the 
synthesized plasmid, pRK2103 (11), and B. avium 197N. These mating plates looked more 
typical of tri-parental mating plates, with fewer colonies forming in the first quadrant (Figure 6). 
These colonies were passaged on kan plates initially. Chromosomal DNA was extracted and 
PCR was done utilizing the new primers that were designed (Table S1) to verify that the 
construct had crossed over into the chromosome during the tri-parental mating.  
 
Figure 6. Tri-Parental Mating Selection Plate with Synthesized Plasmid. This LB plate 
contained kanamycin and naladixic acid to select for the putative B. avium transconjugants and 
displays a typical number of colonies arising from a tri-parental mating. 
 Different combinations of the ProCjaTra-F, ProCjaTra-R, CjaO-F, and CjaO-R primers 
were used to verify the first crossover event into B. avium; a temperature gradient was used to 
assess which annealing temperature yielded the most robust singular bands. The ProCjaTra-
F/ProCjaTra-R primer set was a pair that gave the properly sized band on the gel (1,519 base 




just over 1,000 base pairs. This is believed to be the amplicon of the wild type copy of baa1 that 
would also appear in the transconjugants after the first crossover occurs Annealing temperatures 
over 60°C gave more distinct, but less intense banding patterns whereas annealing temperatures 
under 60°C gave less distinct but higher intensity bands. When using this primer set again, 60°C 
was chosen as the annealing temperature. 
 
Figure 7. Verification of the First Crossover using a Temperature Gradient PCR. Gel 
electrophoresis of a temperature gradient PCR reaction on the chromosome of one sample 
(called BPCT-1)of the putative transconjugants to verify the first crossover. The annealing 
temperature ranged from 55°C to 68°C (indicated above each lane). ProCjaTra-F and 
ProCjaTra-R primers were used. The arrow on the left is indicating the positive control band 
and the arrow on the right is indicating the band of interest.  
The CjaO-F/ ProCjaTra-R primer combination also resulted in the expected band size of 




beneath it, just above the 1,000 base pair marker. Future reactions with this primer set used 65°C 
as the chosen annealing temperature. 
 
Figure 8. Verification of the First Crossover using a Temperature Gradient PCR Using CjaO-
F and ProCjaTra-R Primer Combination. Gel electrophoresis of a temperature gradient PCR 
reaction on the chromosome of one sample (BPCT-1)of the putative transconjugants to verify the 
first crossover. The annealing temperature ranged from 55°C to 68°C. CjaO-F and ProCjaTra-R 
primers were used. The arrow on the left is indicating the positive control band and the arrow on 
the right is indicating the band of interest. 
These results indicated that the first crossover event was successful, and we had 
recombinant B. avium transconjugant. Next, kanamycin was removed from the media to allow 
the loss of the plasmid backbone from the chromosome. Unusual colony morphologies were 
observed during this passaging process.  Interestingly, these morphologies were not when the 




were opaque, mucosal, and punctiform. After taking the selection away, a mixed morphology 
arose (Figure 9). Colonies were still opaque and mucosal, but some colonies were bigger and 
some remained punctiform. 
  
  
Figure 9. Flow Chart Diagram and Results of Mixed Colony morphology study. A flow chart 
that indicates the passaging of colonies from one plate to another, the type of media they were 
transferred to, and the resulting colony sizes. The green plate indicates the selection plate that 
the tri-parental mating was plated on. The blue plates indicate growth of punctiform colonies. 





Kanamycin selection was removed and two B. avium clones were serially passaged in LB 
broth. Cultures were diluted and plated to obtain isolated colonies. Of these two separate plates 
containing isolated colonies, chromosomal DNA was extracted from five colonies from each 
plate. The CjaO-F/ ProCjaTra-R primer pair was used in a PCR reaction to validate the second 
crossover, and thus the completion of homologous recombination. The positive control displayed 
a correct band size of 1,215 base pairs (Figure 10). Other nonspecific bands were present in the 
positive control. All samples with the exception of sample 2-13 displayed a prominent band at 
the expected size—approximately 2,000 base pairs. Sample 2-13 displayed a prominent band at 
approximately 1,200 base pairs (Figure 10). All samples displayed multiple nonspecific bands. 
Figure 10. Verification of the Second Crossover on Ten Different Passaged B. avium 
Transconjugants. PCR was done on chromosomal DNA to verify the second crossover event, 
resulting in the loss of the wild type copy. The annealing temperature was 65°C and CjaO-F and 
ProCjaTra-R primers were used. The green arrows indicate the positive control band at 1215 bp 
(left) and successful transconjugant (center). The purple arrow (right) indicates a nonspecific 




 A follow-up PCR reaction was completed to reduce the nonspecific bands by using a 
higher annealing temperature. Both CjaO-F/ ProCjaTra-R and ProCjaTra-F/ ProCjaTra-R 
primers were used. The ProCjaTra-F/ ProCjaTra-R primer set used a 68°C annealing temperature 
whereas the CjaO-F/ ProCjaTra-R primers used a 69°C annealing temperature. Random bands 
were visible for 1-15 using the ProCjaTra-F/ProCjaTra-R primer set. Also, a band mirroring the 
positive control at 1,500 base pairs was visible in 2-13 (Figure 11). However, the intensity was 
weak and there were still other nonspecific bands. When using the CjaO-F/ ProCjaTra-R 
primers, no bands were visible in  the 1-15 sample indicating the cjaA gene was not present in 
that sample’s chromosome. This confirmed 1-15 was a negative transconjugant, but still showed 
the possibility of 2-13 being a true transconjugant because the largest and brightest band matched 
the positive control at approximately 1,200 base pairs.  
 
Figure 11. Verification of Recombinant B. avium clones containing the baa1::cjaA construct. 
Gel electrophoresis of a PCR reaction on the samples 1-15 and 2-13 using ProCjaTra-F and 
ProCjaTra-R primers at 68°C and CjaO-F and ProCjaTra-R primers at 69°C. The mint green 
arrows indicate the positive control band at 1215 bp (left) and successful transconjugant 2-13 





This purpose of this project was to construct a recombinant B. avium strain that could be 
used as a heterologous vaccine platform to combat the causative agent of food poisoning, C. 
jejuni, and simultaneously immunize against the causative agent of bordetellosis in turkeys, B. 
avium. This vaccine could be administered to turkeys to combat bordetellosis and reduce 
Campylobacter contamination of poultry products.  Doing so would indirectly reduce human 
food poisoning. Making a vaccine that combined would immunize against a human pathogen and 
an avian pathogen would give turkey farmers an economic incentive to actively advocate for this 
vaccine. All parties benefit, including turkey farmers, the poultry, and the consumers. This 
vaccine could relieve multiple related illnesses. 
Though initially expression of the construct via plasmid was the ideal, getting the 
construct into a plasmid that replicated in B. avium proved problematic. Tri-parental matings 
with a recombinant suicide plasmid had to be done to deliver the baa1-cjaA construct into the 
chromosome to produce a stable chimera. This was the most direct approach with the greatest 
likelihood for expression. To produce the recombinant suicide plasmid, molecular cloning of an 
antigenic C. jejuni gene (i.e., cjaA) into the passenger region of the Baa1-encoding 
autotransporter was the primary strategy. Since the Baa1 autotransporter was shown to be 
involved in tracheal cell attachment and is also antigenic, this protein was a good candidate for 
the heterologous vaccine platform. Apparent instability of the C. jejuni genes in the B. avium 
chromosome led to the synthesis of the plasmid and simultaneous codon optimization of the cjaA 
gene as a way to combat the instability. After tri-parental mating and primer design, first and 
second crossovers in the process of homologous recombination were verified resulting in a 




 Multiple attempts were made to verify that the construct crossed over into the B. avium 
chromosome. Various annealing temperatures, polymerases, and controls were used to detect the 
construct to no avail. However, evidence that other regions of the chromosome were amplifiable 
(Figure 5) led to the conclusion that this was not necessarily a matter of PCR, but rather 
instability of the C. jejuni- containing construct within the B. avium chromosome. B. avium has a 
GC content of 61% whereas C. jejuni has a GC content of approximately 30%. This difference 
impacts translation of proteins within these two organisms and is thought to be a main reason of 
the instability of the construct. Since other regions of the chromosome were amplifiable, it was 
reasonable to conclude that the specific C. jejuni regions were not maintained due to instability 
as a result of GC content incompatibility. In theory, synthesizing the construct would make the 
cjaA region more stable when put in the B. avium chromosome. 
 Aside from synthesizing the construct, PCR optimization played a major role in this 
project. For example, when verifying the first crossover using ProCjaTra-F/ProCjaTra-R (Figure 
7) and CjaO-F/ ProCjaTra-R (Figure 8), unexpected nonspecific bands were present in the 
samples, but were not in the positive control that was the synthesized plasmid. These bands may 
have been showing that some primer was annealing to the wild type copy of the promoter/ 
transporter regions that would have still been in the chromosome after the first crossover.  
In an attempt to verify that 2-13 was indeed positive for the cjaA region, multiple PCR 
reactions were completed. Nonspecific bands were present (Figure 11), but there were fewer than 
the first round of PCR verification for the second crossover. This gel showed bands in the 
expected size range though, which was convincing evidence that a stable chimera was produced, 
but more conclusive evidence would be preferable. It is still unclear as to why a clean PCR 




that they should be designed to be longer and potentially with a higher annealing temperature. 
Different strategies to primer design should be tested for optimization of PCR to obtain a larger 
product yield. Eventual sequencing of the chimera should be done as the most conclusive 
evidence to show the cjaA construct was transferred into the chromosome. Essentially, the part of 
the process proving to be the most difficult was not the mating itself, but rather the detection and 
verification of the Campylobacter gene in the B. avium chromosome.  
The size difference in colonies when removing kanamycin resistance was an interesting 
secondary finding of this study. This morphology difference may be due in part to the expression 
of the cjaA gene in B. avium. A C. jejuni gene has never been inserted into baa1 before, so 
phenotypic consequences of doing so were unknown. If this insertion is unknowingly reducing 
the fitness of the B. avium cell, the second crossover is more likely to regenerate the wild type 
copy of the gene rather than the mutation (13). It is quite possible that the different sizes of the 
colonies correspond to which copy of baa1 they contained. If the morphology was truly due to 
the expression of CjaA in a B. avium cell, future expression studies can potentially elucidate why 
the morphologies differed.  
 In this study, we continued the construction of a heterologous vaccine combatting the 
causative agent of food poisoning and bordetellosis, C. jejuni and B. avium respectively. Future 
work will involve the testing of the transconjugant 2-13 in a turkey tracheal cell adhesion assy. 
Previous work showed that loss of Baa1 reduced B. avium adhesion to the host cell, but did not 
affect infection rate in turkeys (5). It is important that this mutant version of Baa1 adheres to the 
host to elicit an immune response. A preliminary study using standard methodology (10) will be 




cell. In vivo studies facilitated by partners at the VA/MD School of Veterinary Medicine (VT) 






Table S1. Primers for the Synthesized Plasmid Containing the Optimized ProCjaTra Gene 
Primer Name Sequence (5’ to 3’) Tm (°C) 
ProCjaTra-F TAGGCCTCTATGCGACGCGC 66 
ProCjaTra-R AGCAGGCGGTACTCGTAAGGC 66.47 
CjaO-F TCACCATCATCATGCGGCAGCG 66.4 
CjaO-R ATCACCACGTCGTCGGCCTTC 66.47 
NewCjaJunct1-F TCAACAGTGGCGGCACCGGTCA 68.26 
NewCjaJunct1-R GGCCTTCACCTCGTCGCCGAAAT 68.12 
NewCjaJunct2-F CCCAGGGCGGAAAAATCGTGCTC 68.12 






Figure S1. Campylobacter Regions Absent in B. avium Chromosome. Gel electrophoresis 
image showing colony PCR of putative transconjugants. No Campylobacter bands are shown 
indicating instability in the B. avium chromosome. The arrow is indicating the proper band size 
of the flaA control at 912 base pairs. 
Figure S2. Amplifiable KanR Gene Amplifiable in Putative Transconjugants. Though the 
Campylobacter gene was not present after PCR analysis, the kanamycin resistance gene was 
amplifiable via PCR on the chromosomes of the putative transconjugants. The arrow is 
indicating the positive control band of the kanamycin resistance gene at just under 500 base 
pairs.  
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